Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Small Cell Lung Carcinoma 19Ovarian Neoplasms 17Neuroblastoma 15Fallopian Tube Neoplasms 13Neoplasms 6Carcinoma, Ovarian Epithelial 6Ganglioneuroblastoma 5Brain Neoplasms 4Uterine Cervical Neoplasms 3Recurrence 3Neoplasm Metastasis 3Lung Neoplasms 3Glioma 3Central Nervous System Neoplasms 3Sarcoma, Ewing 2Rhabdoid Tumor 2Retinoblastoma 2Medulloblastoma 2Leukemia, Myeloid, Acute 2Wilms Tumor 1Thrombocythemia, Essential 1SCLC, Extensive Stage 1SCLC 1Rhabdomyosarcoma 1Retinal Neoplasms 1Primary Myelofibrosis 1Polycythemia Vera 1Pleuropulmonary blastoma 1Peritoneal Neoplasms 1Pediatric Brain Tumor 1

Interventions

Vincristine 1Topotecan 1Razoxane 1Ifosfamide 1Etoposide 1Doxorubicin 1Dexrazoxane 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Localized Extraskeletal Ewing Sarcoma × Topotecan × 1 year × Clear all
NCT01231906 2026-01-23

Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma

Children's Oncology Group

Phase 3 Completed
642 enrolled 11 charts
Sarcoma

Localized Extraskeletal Ewing Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡